Skip to content

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05897697
Acronym
PREFER-PP
Enrollment
122
Registered
2023-06-09
Start date
2021-09-24
Completion date
2022-10-07
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related, Venous Thromboembolism

Brief summary

The preferences of pregnant women for postpartum thromboprophylaxis are largely unknown. The aims of this transversal study are to elicit the preferences of pregnant/postpartum women about postpartum thromboprophylaxis in semi-structured interviews, and to estimate the utility of the relevant health states (pulmonary embolism, deep vein thrombosis, postpartum hemorrhage, subcutaneous injections). In this second aim, the investigators will also compare the effect of 2 different techniques to estimate utilities (standard gamble vs. time trade-off), using a randomization of these techniques.

Interventions

OTHERInterview

Structured interview

Sponsors

Marc Blondon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* women * ongoing pregnancy or within 7 days of delivery * fluency in French or English

Exclusion criteria

* fetal or neonatal death

Design outcomes

Primary

MeasureTime frameDescription
Preference for postpartum thromboprophylaxis90 days of deliveryRisk of postpartum venous thromboembolism at which thromboprophylaxis is preferred
Quality-of-life of pulmonary embolism, deep vein thrombosis, postpartum hemorrhage and subcutaneous injections90 days of deliveryMeasurements of utilities of pulmonary embolism, deep vein thrombosis, postpartum hemorrhage and subcutaneous injections, by standard gamble and time trade-off methods

Countries

France, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026